Systems and methods for protein expression
AssigneeExcepgen Inc.
InventorsBarbara MERTINS, Thomas FOLLIARD, Imre MÄGER
Life of this patent
Estimating the term…
Loading patent…
AssigneeExcepgen Inc.
InventorsBarbara MERTINS, Thomas FOLLIARD, Imre MÄGER
Estimating the term…
The present disclosure provides methods and compositions for the improved expression of target proteins via the co-expression of an enhancer protein in a subject. Provided herein are methods for expressing a target protein in a subject comprising administering a vector system of one or more polynucleotides encoding a target protein and an enhancer protein, wherein the polynucleotides are operatively linked, and wherein the enhancer protein is an inhibitor of nucleocytoplasmic transport (NCT) and/or the enhancer protein is selected from the group consisting of a picornavirus leader (L) protein, a picornavirus 2A protease, a rhinovirus 3C protease, a herpes simplex virus (HSV) ICP27 protein, and a rhabdovirus matrix (M) protein.
A method of expressing a target protein in a subject in need thereof, comprising administering to the subject a system comprising:
(canceled)
7-11. (canceled)
18-32. (canceled)
36-37. (canceled)
A method of treating a disease in a subject, wherein the disease is caused by, correlated with, or associated with a target protein, comprising administering to the subject a system comprising:
40-47. (canceled)
52-61. (canceled)
64-65. (canceled)
67-98. (canceled)
A composition comprising a vector system comprising one or more vectors, the one or more vectors, comprising:
101-103. (canceled)
Dependencies are inferred from the claim text.